MYO Myomo Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MYO

Price (delayed)

$1.64

Market cap

$64.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.34

Enterprise value

$73.24M

?
Relative Growth: Rel. Growth: 42
Relative Strength: Rel. Strength: 95
Relative Valuation: Rel. Valuation: 22
Relative Profitability: Rel. Profitability: 20

Myomo, Inc. is a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. ...

Highlights
The company's gross profit rose by 9% QoQ and by 4.8% YoY
The revenue has increased by 6% year-on-year and by 5% since the previous quarter
Myomo's net income has plunged by 56% YoY but it has increased by 4% from the previous quarter
The EPS has shrunk by 55% YoY but it rose by 6% QoQ
MYO's equity has dropped by 67% year-on-year and by 35% since the previous quarter
The company's debt has surged by 62% YoY and by 6% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.myomo.com

Key stats

What are the main financial stats of MYO

MYO stock price

How has the Myomo stock price performed over time
Intraday
0%
1 week
27.13%
1 month
-5.2%
1 year
72.81%
YTD
80.22%
QTD
57.69%

Financial performance

How have Myomo's revenue and profit performed over time
Revenue
$43.26M
Gross profit
$29.57M
Operating income
-$11.7M
Net income
-$14.51M
Gross margin
68.4%
Net margin
-33.5%
Myomo's net income has plunged by 56% YoY but it has increased by 4% from the previous quarter
The company's net margin fell by 46% YoY but it rose by 9% QoQ
The operating income has contracted by 26% YoY but it has grown by 17% from the previous quarter
The operating margin has grown by 21% from the previous quarter but it has contracted by 19% YoY

Price vs fundamentals

How does MYO's price correlate with its fundamentals

Growth

What is Myomo's growth rate over time

Valuation

What is Myomo stock price valuation
P/E
N/A
P/B
10.87
P/S
1.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.69
The EPS has shrunk by 55% YoY but it rose by 6% QoQ
The price to book (P/B) is 186% more than the last 4 quarters average of 3.8 and 117% more than the 5-year quarterly average of 5.0
MYO's equity has dropped by 67% year-on-year and by 35% since the previous quarter
The stock's P/S is 80% above its last 4 quarters average of 0.9 but 46% below its 5-year quarterly average of 3.0
The revenue has increased by 6% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Myomo business performance
MYO's ROE has dropped by 179% year-on-year and by 24% since the previous quarter
The return on assets has declined by 49% year-on-year
Myomo's return on invested capital has increased by 35% YoY and by 13% QoQ
The ROS fell by 25% YoY but it rose by 13% QoQ

Dividends

What is MYO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYO.

Financial health

How did Myomo financials performed over time
Myomo's total assets is 20% higher than its total liabilities
The total liabilities has grown by 40% YoY and by 6% from the previous quarter
The quick ratio has contracted by 20% from the previous quarter and by 8% YoY
MYO's equity has dropped by 67% year-on-year and by 35% since the previous quarter
The debt to equity has soared by 63% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.